Evidence map›Paper›PMID 26418566›Full record

ArticlePloS one2015

Apamin Boosting of Synaptic Potentials in CaV2.3 R-Type Ca2+ Channel Null Mice.

Kang Wang, Melissa H Kelley, Wendy W Wu, John P Adelman, James Maylie

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. R-type voltage-gated CaCell reports · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kang WangVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States of America.
Melissa H KelleyVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States of America.
Wendy W WuDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon 97239, United States of America.
John P AdelmanVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States of America.
James MaylieDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon 97239, United States of America.
Oregon Health & Science University · USVollum Institute · US

Funding

Molecular Physiology of the SK2 Channels in CA1 NeuronsR01NS038880 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MAYLIE, JAMES G · 2000 to 2017
$6.0M
Coupled LTP-dependent trafficking of synaptic SK channels and NMDARsR01MH093599 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI ADELMAN, JOHN P, MAYLIE, JAMES G · 2012 to 2015
$1.2M
NIMH NIH HHS 5R01MH093599-03NIMH NIH HHS R01 MH093599NINDS NIH HHS 5R01NS038880-15NINDS NIH HHS R01 NS038880
6 · The paper itself

Abstract

SK2- and KV4.2-containing K+ channels modulate evoked synaptic potentials in CA1 pyramidal neurons. Each is coupled to a distinct Ca2+ source that provides Ca2+-dependent feedback regulation to limit AMPA receptor (AMPAR)- and NMDA receptor (NMDAR)-mediated postsynaptic depolarization. SK2-containing channels are activated by Ca2+ entry through NMDARs, whereas KV4.2-containing channel availability is increased by Ca2+ entry through SNX-482 (SNX) sensitive CaV2.3 R-type Ca2+ channels. Recent studies have challenged the functional coupling between NMDARs and SK2-containing channels, suggesting that synaptic SK2-containing channels are instead activated by Ca2+ entry through R-type Ca2+ channels. Furthermore, SNX has been implicated to have off target affects, which would challenge the proposed coupling between R-type Ca2+ channels and KV4.2-containing K+ channels. To reconcile these conflicting results, we evaluated the effect of SK channel blocker apamin and R-type Ca2+ channel blocker SNX on evoked excitatory postsynaptic potentials (EPSPs) in CA1 pyramidal neurons from CaV2.3 null mice. The results show that in the absence of CaV2.3 channels, apamin application still boosted EPSPs. The boosting effect of CaV2.3 channel blockers on EPSPs observed in neurons from wild type mice was not observed in neurons from CaV2.3 null mice. These data are consistent with a model in which SK2-containing channels are functionally coupled to NMDARs and KV4.2-containing channels to CaV2.3 channels to provide negative feedback regulation of EPSPs in the spines of CA1 pyramidal neurons.

Indexed as

AnimalsApaminCA1 Region, HippocampalCalciumCalcium Channels, R-TypeCation Transport ProteinsEvoked PotentialsExcitatory Postsynaptic PotentialsMice, Inbred C57BLMice, KnockoutPatch-Clamp TechniquesPyramidal CellsSpider VenomsSynaptic PotentialsApaminCacna1e protein, mouseCalciumCalcium Channels, R-TypeCation Transport ProteinsSNX 482Spider Venoms

Identifiers

PMID26418566
PMCPMC4587947
OpenAlexW2338450765

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.